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Abstract
Background/Aims: Cell migration and extracellular matrix remodeling underlie normal mammalian
development and growth as well as pathologic tumor invasion. Skeletal muscle is no exception, where
satellite cell migration replenishes nuclear content in damaged tissue and extracellular matrix reforms
during regeneration. A key set of enzymes that regulate these processes are matrix metalloproteinases
(MMP)s. The collagenase MMP-13 is transiently upregulated during muscle regeneration, but its
contribution to damage resolution is unknown. The purpose of this work was to examine the importance
of MMP-13 in muscle regeneration and growth in vivo and to delineate a satellite cell specific role for this
collagenase. Methods: Mice with total and satellite cell specific Mmp13 deletion were utilized to
determine the importance of MMP-13 for postnatal growth, regeneration after acute injury, and in chronic
injury from a genetic cross with dystrophic (mdx) mice. We also evaluated insulin-like growth factor 1
(IGF-1) mediated hypertrophy in the presence and absence of MMP-13. We employed live-cell imaging
and 3D migration measurements on primary myoblasts obtained from these animals. Outcome measures
included muscle morphology and function. Results: Under basal conditions, Mmp13-/- mice did not
exhibit histological or functional deficits in muscle. However, following acute injury, regeneration was
impaired at 11 and 14 days post injury. Muscle hypertrophy caused by increased IGF-1 was blunted with
minimal satellite cell incorporation in the absence of MMP-13. Mmp13-/- primary myoblasts displayed
reduced migratory capacity in 2D and 3D, while maintaining normal proliferation and differentiation.
Satellite cell specific deletion of MMP-13 recapitulated the effects of global MMP-13 ablation on muscle
regeneration, growth and myoblast movement. Conclusion: These results show that satellite cells provide
an essential autocrine source of MMP-13, which not only regulates their migration, but also supports
postnatal growth and resolution of acute damage. © 2020 The Author(s). Published by Cell Physiol
Biochem Press GmbH&Co. KG
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Abstract
Background/Aims: Cell migration and extracellular matrix remodeling underlie normal
mammalian development and growth as well as pathologic tumor invasion. Skeletal muscle
is no exception, where satellite cell migration replenishes nuclear content in damaged tissue
and extracellular matrix reforms during regeneration. A key set of enzymes that regulate these
processes are matrix metalloproteinases (MMP)s. The collagenase MMP-13 is transiently
upregulated during muscle regeneration, but its contribution to damage resolution is
unknown. The purpose of this work was to examine the importance of MMP-13 in muscle
regeneration and growth in vivo and to delineate a satellite cell specific role for this collagenase.
Methods: Mice with total and satellite cell specific Mmp13 deletion were utilized to determine
the importance of MMP-13 for postnatal growth, regeneration after acute injury, and in
chronic injury from a genetic cross with dystrophic (mdx) mice. We also evaluated insulin-like
growth factor 1 (IGF-1) mediated hypertrophy in the presence and absence of MMP-13. We
employed live-cell imaging and 3D migration measurements on primary myoblasts obtained
from these animals. Outcome measures included muscle morphology and function. Results:
Under basal conditions, Mmp13-/- mice did not exhibit histological or functional deficits in
muscle. However, following acute injury, regeneration was impaired at 11 and 14 days post
injury. Muscle hypertrophy caused by increased IGF-1 was blunted with minimal satellite cell
incorporation in the absence of MMP-13. Mmp13-/- primary myoblasts displayed reduced
migratory capacity in 2D and 3D, while maintaining normal proliferation and differentiation.
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Satellite cell specific deletion of MMP-13 recapitulated the effects of global MMP-13 ablation
on muscle regeneration, growth and myoblast movement. Conclusion: These results show
that satellite cells provide an essential autocrine source of MMP-13, which not only regulates
their migration, but also supports postnatal growth and resolution of acute damage.
Introduction

© 2020 The Author(s). Published by
Cell Physiol Biochem Press GmbH&Co. KG

Tissue repair and development are facilitated by well-coordinated remodeling of the
extracellular matrix (ECM), as well as migration of cells through the ECM to form new tissues.
Cell movement through the ECM is aided by the ability of the cells to digest macromolecules
in the matrix, and proteolytic enzymes that degrade ECM proteins are essential. These
processes are important for successful structural formation of tissues and wound healing [1,
2]. Alternatively, disease processes such as tumor invasion and metastasis take advantage
of the same mechanisms to enable cancer cells to escape through biological barriers [3].
Similar mechanisms are used by skeletal muscle, which has a renowned ability to repair
and regenerate following injury. Much of the regenerative capacity of skeletal muscle is
attributable to the resident muscle stem cell population, the satellite cell [4, 5]. Satellite
cells act in coordination with a milieu of inflammatory and stromal cells present in damaged
muscle to resolve the injury and restore skeletal muscle structure. This heterogeneous cell
population within the muscle tissue secretes many factors to help guide cell maturation,
degrade and re-construct ECM, and re-form muscle fibers. Of these factors, the matrix
metalloproteinases (MMP) family of proteinases is important for the ECM remodeling
process, where their primary function is to degrade components of the ECM [6]. In addition
to actions on the ECM, MMPs have also been shown to regulate satellite cell migration [7, 8],
in part by altering the matrix and lowering the barriers for cell movement.
The tight regulation of MMPs occurs at many levels including transcription, activation,
and inhibition by the tissue inhibitors of metalloproteinases (TIMPs) [9]. During development,
repair, and regeneration, MMPs are upregulated and activated to remodel the ECM. However,
without regulation over-active MMPs can cause several pathological conditions [10-12].
Alternatively, loss of MMP activity leads to pathologies including stalled development
[13], unresolved bone repair [14], diminished wound healing [15], and impaired skeletal
muscle repair [16]. Hence, regulation of MMP activity is a significant factor for successful
skeletal muscle regeneration. Of the more than 2 dozen MMPs identified, the gelatinases
(MMP-2 and -9), collagenases (MMP-1 and -13), and the membrane anchored MT1-MMP/
MMP-14 have been examined in skeletal muscle [7, 17-21]. These MMPs are upregulated to
enable regeneration with distinct time courses. For instance, during the resolution of acute
damage, MMP-9 is quickly activated in the injured muscle and then disappears, whereas
MMP-2, MMP-14, and MMP-13 appear in the later phases of the repair process [7, 20]. By
extension, the continual cycles of degeneration and regeneration associated with several
muscular dystrophies is accompanied by sustained elevation of MMP levels [7]. As the
dystrophic muscles are progressively replaced by fibrosis [22], heightened MMP activity
may be compensatory to counter fibrosis, or part of the initiation of ECM remodeling. Loss of
MMP-2 from the dystrophic mdx mouse resulted in a more pronounced phenotype with lack
of proper regeneration and angiogenesis [23]. The role of MMP-9 in the mdx mice is more
complex, with loss of MMP-9 and overexpression of MMP-9 both resulting in an improved
phenotype [24, 25] as well as reports of a beneficial impact early followed by a detrimental
effect later in the lifespan [25]. While the effects of MMPs on the muscle ECM integrity have
been studied, little attention on how they contribute to or alter satellite cell function in the
regenerating environment has been addressed.
A role for MMP-13 in myoblast migration was originally noted in a wound healing study
that observed high expression of MMP-13 in migrating myoblasts [26]. This is consistent
with the ability of MMP-13 to modulate C2C12 myoblast migration in vitro [7]. In addition to
its actions on cell migration, MMP-13 is a collagenase capable of cleaving native interstitial
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collagens [27], providing a counter weight to the abundant interstitial collagen present in
fibrosis. MMP-13 is a potent ECM degrading enzyme with activity against multiple collagens,
proteoglycans, and fibronectin as well as activating other MMPs, including MMP-2 and
MMP-9 [28]. MMP-13 can also support regeneration through its role in releasing vascular
endothelial growth factor (VEGF) from the ECM to accommodate angiogenesis [29]. In
comparison to its other family members, MMP-13 levels are very low, suggesting that its
actions on overall ECM proteolysis may be less than more abundant MMPs. However, the
local concentration of MMP-13 in the vicinity of a cell that secretes it may be sufficient to
provide the ECM remodeling necessary for that particular cell. No previous studies have
specifically manipulated MMP-13 in primary muscle cells or in muscle to examine its
necessity during phases of matrix remodeling. The purpose of this work is to examine the
importance of MMP-13 in muscle regeneration and growth in vivo using global genetic
ablation of MMP-13 [13], and to delineate a satellite cell specific role for this collagenase. We
hypothesized that myoblasts lacking MMP-13 would have impaired migration, resulting in
impaired regenerative capacity and matrix remodeling in vivo.
Materials and Methods

Animals
The Animal Care and Use Committees at the University of Pennsylvania and the University of Florida
approved all experiments in this study. Male and female mice were used for all studies, unless otherwise
stated. Mice were maintained in the animal facility under a 12-hour light/dark cycle. Animals had ad libitum
access to food and water. Mouse lines included those with whole body ablation of Mmp13 (Mmp13-/-) [13, 30]
and C57BL/6 strain matched wildtype (WT) controls. Mmp13-/- mice were crossed with mdx mice, a model
for DMD. Experiments on male Mmp13-/-:mdx and mdx mice were carried out in mice at 12-weeks of age and
a small subset at 1 year of age. In addition, mice with satellite cell specific deletion of Mmp13 (scMmp13fl/fl)
were generated. Mice harboring floxed exons 3-5 of Mmp13 (Mmp13fl/fl) [30] (005710, Jackson Laboratory)
were crossed with mice carrying tamoxifen-inducible Cre recombinase under the Pax7 promoter (Pax7CE)
[31, 32] (012476, Jackson Laboratory), and also crossed with the ROSAmT/mG reporter mouse (007676,
Jackson Laboratory) [33], which widely expresses membrane localized TdTomato prior to Cre exposure and
expresses GFP in Cre expressing cells, to monitor deletion. Intraperitoneal injection of 0.2 mg/g bodyweight
of tamoxifen (TAM) dissolved in corn oil was administered for five consecutive days prior to the experimental
timepoint to induce satellite cell deletion of Mmp13 (+scMmp13fl/fl). Controls included scMmp13fl/fl mice
that received intraperitoneal corn oil (vehicle) injections (-scMmp13fl/fl), and scMmp13+/+ mice injected
with TAM (+scMmp13+/+). Genotypes of mouse lines were determined by PCR with oligonucleotides listed
in Supplementary Table 1 (for all supplemental material see www.cellphysiolbiochem.com). Experiments
were conducted on age- and sex-matched mice.
Muscle Acute Injury
For muscle injury experiments mice were injected in the anterior hind limb, targeting the TA muscle,
with 50 ul of 10 μM CTX (Sigma-Aldrich). This instigates acute muscle damage with a well-documented time
course of regeneration from which muscles were harvested after 7, 11, 14, or 21 days. Initial injection of CTX
took place in young adult mice aged 10-15 weeks.

Viral Delivery of IGF-1
IGF-1 mediated hypertrophy was induced by injection of adeno-associated virus (AAV) harboring Igf1a
cDNA as previously described [34]. Specifically, 2.5 x 1010 copies self-complementing AAV 2/8 in 50 µL PBS
was injected into the anterior compartment of the lower hindlimb, with the contralateral limb receiving
PBS only. Mice were injected at 2 months of age, and were then sacrificed one month after injection.
Following this, both TA and EDL muscles were dissected and weighed. TA muscles were flash frozen for
IGF-1 quantification, and the EDL muscles embedded in OCT and frozen in melting isopentane muscles
and stored at −80°C for subsequent morphological analysis. Tissue IGF-1 levels were determined in the TA
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muscles using the Rat/Mouse IGF-1 Enzyme-linked Immunosorbent ELISA-Kit (R&D Systems, Cat#MG100)
as described previously [35] and according to the manufacturer’s instructions. Data are expressed as ng/g
tissue.

Muscle Mechanics
Mice were anesthetized with a ketamine/xylazine cocktail. Muscles were dissected and incubated in a
bath of modified Ringer’s solution (119 mM NaCl, 4.74 mM KCl, 3.36 mM CaCl2, 1.18 mM KH2PO4, 1.18 mM
MgSO4, 25 mM HEPES, and 2.75 mM glucose) gas equilibrated with 95% O2-5% CO2. The proximal and distal
tendons of the EDL were tied with 6-0 silk suture, and for diaphragm suture was tied to the central tendon
on one end and two adjacent ribs on the other. The mechanical measurements were made on an apparatus
previously described (Aurora Scientific, Ontario, Canada) [36], on muscles maintained in modified Ringers
solution at 25°C. Optimum muscle length (Lo) was determined with iterative manual length extensions to
reach maximal force production from a supramaximal stimulation to induce twitch. Muscle physiological
cross-sectional area (PCSA) was determined as previously described using Lf/Lo of 0.45 for EDL and 1.0 for
diaphragm. Maximum isometric twitch force was measured and then after 20 s maximum isometric tetanus
was measured during a 500 ms stimulation. The twitch and tetanus forces were measured a total of three
times with a 5-minute interval between each set of stimulations. For eccentric contraction (ECC) induced
injury an isometric maximal force was produced by supramaximal stimulation for 500 ms with a 10% strain
during an additional 200 ms of supramaximal stimulation. The eccentric contraction was repeated 5 times
with a period of 5 minutes between each contraction. An index of ECC induced damage was calculated by the
isometric force following the ECC contractions compared to the isometric force prior to the ECC contractions
[37].
Passive muscle mechanics were measured as previously described [38]. Briefly, each muscle underwent
strains of 2.5, 5, 7.5, 10, and 12.5%. Muscles were preconditioned for each strain with a cyclical strain at
1 Hz for 5 s. The muscle then underwent a ramp strain at 1 Lo /s and allowed to stress relax for 2 minutes.
The stress at 2 minutes was used as the elastic stress. The muscles were allowed to relax for 20 s prior to the
following induced strain. The elastic stiffness was calculated from the tangent modulus of the elastic stress
at 10% strain.
Muscle Histochemistry
Muscle cryosections were cut in cross section of 10 μm from the mid belly of the muscle. For
immunofluorescence, sections were washed in PBS, blocked for 1 hour at room temperature in 5% bovine
serum albumin, and incubated in primary antibody at 4°C overnight in a humidified chamber. Primary
antibodies used include laminin (Thermo FB-082A) and CD31 (eBiosciences). The following day sections
were washed with PBS, incubated with fluorescently labeled secondary antibodies (Alexa Fluor 488 goat antirat IgG (H+L) (Invitrogen A-11006), and Alexa Fluor 568 goat anti-rabbit IgG (H+L) (Invitrogen A-11011),
washed again in PBS, and mounted with Vectashield containing DAPI (VectorLabs). In addition, slides were
exposed to mouse IgG alone (Invitrogen A-11029) to assess fiber damage. Negative control slides, incubated
only with the secondary antibodies, were included in each immunostaining. Samples were visualized in a
Leica DMR Fluorescent Phase Contrast Microscope (Leica), equipped with a DFC7000T Microscope camera
(Leica). Images were acquired and processed using the Leica Suite Microscope Imaging software (Leica).
The images of TA and EDL muscles were reconstituted by merging images using Photoshop to contain the
whole cross-section. Analysis of fiber cross-sectional area, proportion of centrally nucleated fibers, and
capillary density were conducted using SMASH software for analysis of skeletal muscle histology [39].
Picrosirius red staining was conducted similarly to previous studies [38]. Briefly, sections were fixed in
4% paraformaldehyde for 10 min, rinsed, air dried, and stained for 1 h in 0.1% (wt/vol) sirius red (SigmaAldrich) dissolved in saturated aqueous picric acid (Sigma-Aldrich). Sections were then washed in two
changes of 0.5% acetic acid, dehydrated in three changes of 100% ethanol, cleared with Citra Solv, and
mounted with Cytoseal. A series of micrographs from each muscle were captured using a ×10 objective on
a Leica DMLP (Leica) scope with a Micropublisher 5.0 (Q Imaging) camera. A custom script was written in
MATLAB (Mathworks) to determine number of pixels stained red and total number of pixels stained.
Collagen packing density was evaluated using picrosirius red-stained muscle sections viewed under
circularly polarized light using the Leica DMLP (Leica) scope, rotating polarizer, rotating analyzer, and dual
quarter wave plates as previously described [38]. A custom script was written in MATLAB to determine the
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number of pixels stained above an intensity threshold in bins determined by 8-bit hue values (245–255
and 0–34 for red, 35–49 for yellow, and 50–115 for green) where high wavelengths represent more densely
packed collagen.
Hydroxyproline content was determined as described in previous studies by our group [38, 40].
Frozen muscle tissue was pulverized on dry ice with careful attention to remove any attached tendon. The
pulverized muscle was weighed, and hydrolyzed overnight in 1 ml of 6 M hydrochloric acid at 105°C. 10 μl
of hydrolysate was mixed with 150 μl isopropanol followed by 75 μl of 1.4% chloramine-T (Sigma, St. Louis,
MO) in citrate buffer and oxidized at room temperature for 10 min. The samples were then mixed with
1 ml of a 3:13 solution of Ehrlich’s reagent [1.5 g of 4-(dimethylamino) benzaldehyde (Sigma); 5 ml ethanol;
337 μl sulfuric acid] to isopropanol and incubated for 45 min at 55°C. Quantification was determined by
extinction measurement of the resulting solution at 558 nm with the inclusion of a standard (0–1,000 μM
trans-4-hydroxy-l-proline; Sigma). Results are reported as micrograms of hydroxyproline per milligrams of
tissue wet weight.

MMP-13 Enzyme Activity
Frozen muscles were lysed with zymogen extraction buffer (100 mM Tris·HCl, 200 mM NaCl, 100
mM CaCl2, and 1% Triton X-100, pH 7.6) to measure MMP-13 activity as previously described [7]. Protein
concentrations were measured by Bradford method (Bio-Rad). Samples were diluted to 100 μg/ml in
assay buffer (50 mM Tris·HCl, 10 mM CaCl2). Trypsin (10 μg/ml) was added for cleavage of the inhibiting
proregion of recombinant MMP-13. All samples were incubated at 37°C for 20 min to facilitate MMP
activation. Soybean inhibitor (80 μM) was added to inactivate trypsin and to prevent nonspecific cleavage.
Activity was assessed using fluorogenic MMP-13--specific substrate (EMD Millipore, Billerica, MA) dissolved
in DMSO. Fluorescence was measured with 325 nm (excitation) and 393 nm (emission) every 10 min for a
total of 120 min using a fluorescence plate reader (SpectraMax M5, Molecular Devices). Each sample was
measured in triplicate. For calculation of MMP activity, each measurement was background-corrected to the
average of the controls containing substrate only at the same time point. The slope of background-corrected
fluorescence vs. time was calculated as a measure of MMP activity for each sample.

Single Fiber Satellite Cell isolation for Live Cell Microscopy
To directly visualize myoblast migration, single fiber cultures were used as a source of satellite cells,
modified from [41]. Briefly, freshly dissected EDL muscles were rinsed in PBS and placed in DMEM containing
2 mg/ml collagenase and incubated at 37°C for 90 minutes with agitation. Collagenase was then rinsed
with DMEM and muscles placed in DMEM + 10% FBS. Muscle was dissociated first by passing through a
wide-bore Pasteur pipette followed by further mechanical separation of fibers with Pasteur pipette. Isolated
single fibers were carefully transferred to another dish with DMEM + 10% FBS and kept at 37°C as fibers
were collected. Single fibers were then transferred again into 4-chamber glass bottom 35 mm dishes coated
in 2 mg/ml matrigel (Corning Life Sciences). Fibers were allowed to attach for approximately 1 hour prior
to addition of myoblast media (F-10 base, 20% FBS, 0.5 μg/ml bFGF, and PBS). Fiber cultures were left
undisturbed for 48 hours and then media was changed with fresh myoblast media or reduced serum myoblast
media (2% FBS). The samples were brought to the School of Dental Medicine Imaging Core (University of
Pennsylvania). DIC and fluorescent signals were acquired with a Nikon A1R confocal microscope equipped
with an automated stage. Cells were maintained at 37°C under 5% CO2 for the duration of the imaging
via a stage-top incubator. Images were captured with a 10x (NA 0.45) objective data analyzed using Nikon
Elements AR 4.30.01 software. Images of the hypercontracted myofiber and surrounding myoblasts were
taken every 15 minutes for a total of 16 hours. Cells were tracked using ImageJ cell tracker plugin [42] and
the velocity, total displacement, and divisions were calculated.

Bulk Satellite Cell Isolation
Satellite cells were isolated as described in [43]. Briefly, freshly dissected TA and gastrocnemius muscles
were rinsed in pre-warmed DMEM and under a dissecting scope and tendon, fat, vessels, and connective
tissue were removed. The muscle was then cut into small fragments and remaining pieces of connective
tissue were removed. Fragments were transferred to DMEM containing 2 mg/ml collagenase (Sigma) and
incubated with agitation at 37°C for 1 hour. Fragments were spun down and washed in DMEM before being
placed in DMEM supplemented with 10% horse serum. Enzymatically digested muscle fragments were then
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mechanically titrated with a wide-bore pasture pipette and a 9” glass pasture pipette. The supernatant was
filtered through a 40 μm cell filter, centrifuged, and suspended in DMEM with 10% horse serum. Cells were
counted using a hemocytometer and used in the transwell migration assay or fusion assay, or differentiated.

Transwell invasion assay
Transwell membranes were used according to the manufactures instructions (Trevigen). The day
prior to satellite cell isolation, 1X basement membrane extract (BME, Trevigen) and 1.5 mg/ml collagen I
(Trevigen) solutions were made and 100 μl was placed on top of a transwell membrane containing 8 μm
pores. Transwells were incubated overnight at 37°C to polymerize the substrate. The following day any
liquid was carefully aspirated from the substrate and 1 x 105 freshly isolated satellite cells from the muscle
bulk in DMEM + 10% horse serum were added to the top of the chamber. On the bottom of the chamber 500
μl of growth media (DMEM with 20% fetal bovine serum, 10% horse serum, and 1% chick embryo extract)
was added. Assembled transwells were incubated for 24 hrs at 37°C with 5% CO2. Following incubation, nonmigrated cells on the upper side of the filter were wiped with Q-tips; the migrated cells attached to the lower
side of the filter were fixed with 4% formaldehyde for 10 min, washed three times with PBS, stained with
crystal violet solution for 30 min, and rinsed with PBS. The filters were cut out from the transwell plates,
mounted onto glass slides with mounting medium, and viewed under a Leica DFC300 light microscope. For
each membrane, 3 fields were randomly chosen and imaged at 20X, and the total number of cells per field
was determined. Each condition was performed in triplicate.
Fusion assay
Satellite cells freshly isolated as described above were centrifuged and resuspended with growth
media. Cell suspension was placed on 24 mm coverslips coated with BME or collagen I within a 6 well plate
at a density of 1 x 105 cells/well. Cells were cultured for 3 days undisturbed and then carefully washed with
DMEM to remove debris and cultured in growth media an additional 3 days. On the 6th day the medium was
changed to DMEM with 10% horse serum to induce differentiation. At 0, 1, and 2 days post differentiation
the cells were fixed with 4% paraformaldehyde for 10 minutes. The cells were then permeabilized with 1%
Triton X-100 and blocked in 5% BSA. Coverslips were incubated with MF20 antibody to label sarcomeric
myosin (MF20, Iowa Developmental Studies Hybridoma Bank) overnight at 4°C. Coverslips were washed
and incubated with secondary antibody (Alexa Fluor 568 goat anti-mouse IgG (H+L) (Invitrogen A-11004),
and phalloidin conjugated to Alexa Fluor 488 (Thermo) for 1 hour at room temperature. Coverslips were
washed and mounted on slides with Vectashield containting DAPI. From each coverslip, 3 images were
obtained at 10X magnification. Nuclei were counted within cells that expressed sarcomeric myosin and
total nuclei. The ratio of nuclei within myotubes expressing sarcomeric myosin to total nuclei is used as the
fusion index.

Gene expression analysis
Total RNA was isolated from TA muscles using Trizol ® Reagent (Life Technologies, #15596018)
and DNAse treated with DNase I recombinant, RNase- free (Roche, #04716728001). cDNA was prepared
using High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, #4368814) according to the
manufacturer’s instructions. Duplicates of cDNA samples were amplified on Step One Plus Real Time PCR
System (Applied Biosystems) using Power SYBR Green PCR Master Mix (Applied Biosystems, #4367659).
The expression level of Mmp2 was determined and normalized to 18S and plotted as mean ± SEM in foldchanges. The oligonucleotide primers used are listed in Supplementary Table 1.
Statistical methods
Analysis of results included two-tailed unpaired students t-test, one-way, or two-way ANOVA followed
by Bonferroni’s post hoc analysis. For two-way ANOVAs, genotype was a main effect along with one of the
following: serum concentration, substrate, days post differentiation, days post cardiotoxin, or muscle.
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Results

Mmp-13 is dispensable in homeostatic muscle
Mice with total ablation of Mmp13 were previously evaluated for the effects on bone
formation, but no role in skeletal muscle had been addressed [30]. We examined mice at 4
and 11 weeks of age to capture a period of active growth. At post-weaning age, both male
and female Mmp13-/- mice were smaller than their age and sex-matched controls, similar to
previous reports ascribing lower body mass to disruption of skeletal development at the
growth plate [30]. By 11 weeks of age, there was no appreciable difference in body weight
(Fig. 1A). Mmp13-/- mice age 11-13 weeks displayed divergent phenotypes with respect to
muscle mass, where males had smaller extensor digitorum longus (EDL) and larger tibialis
anterior (TA) mass, while female muscle masses were similar to wildtype (WT) cohorts (Fig.

Fig. 1. Mmp13-/- muscles exhibit differential size with normal function, vasculature, and ECM. (A) Male and female
Mmp13-/- mice at 4 weeks of age are smaller than age-and sex-matched WT mice (N=3-5 per group), but by 11
weeks of age, no body mass differences are apparent. (B) Muscle masses in 11-week old male Mmp13-/- mice
have smaller absolute EDL mass but larger TA mass when compared to WT mice (N=5 each). Female mice have
no differences in muscle masses between genotypes. (C) When normalized to the body mass, Mmp13-/- male mice
had larger TA but females had smaller EDL muscles. (D) The specific force in muscles from Mmp13-/- mice (N=5)
are similar to WT (N=5) for EDL and diaphragm. (E) WT and Mmp13-/- were visualized with immunofluorescent
staining of laminin for fiber border, CD31 for endothelial cells, and DAPI to visualize DNA from the TA muscle. Scale
bar 50 μm. (F) There was no significant change in the cumulative distribution of fiber areas of Mmp13-/- (N=5)
compared to WT (N=6) TA muscles. (G) There was no difference in the capillary density (the number of capillaries
normalized to fiber number) of the same TA muscles. (H) Picrosirius red staining of TA muscles showed areas
occupied by ECM from WT and Mmp13-/-muscles. Scale bar 50 μm. (I) The area fraction of ECM was similar for
WT (N=6) and Mmp13-/- (N=8) TA muscles. (J) The proportion of loose (green), intermediate (yellow), and dense
(red) collagen was similar for WT (N=4) and Mmp13-/- (N=4) TA muscles. (K) The amount of hydroxyproline was
similar for WT (N=4) and Mmp13-/- (N=4) quadriceps muscles. The * represents a significant (p<0.05) difference
between genotype.
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1B). Normalized muscle mass of male TA muscles was also larger, while female EDL muscles
were smaller in Mmp13-/- mice (Fig. 1C). Muscles from Mmp13-/- mice maintained normal
function in terms of force normalized to cross sectional area (specific force) (Fig. 1D) and
passive stiffness (Supplementary Fig. 1), in both the EDL and diaphragm. Cross sections from
TA muscles were immunostained for laminin and CD31 to determine if Mmp13 ablation led
to changes in fiber dimensions or vascularization, respectively (Fig. 1E), as MMP-13 plays a
role in angiogenesis that could overlap with defects in muscle growth [44]. The cumulative
distribution of fiber sizes showed no significant difference between the Mmp13-/- and WT TA
muscles for unchallenged adult mice (Fig. 1F). Similarly, there was not a significant decrease
in capillary density of the Mmp13-/- TA muscles as measured by CD31 labeled capillaries
per muscle fiber (Fig. 1G). As MMP-13 is an archetypal collagenase, we anticipated higher
collagen levels in its absence. However, the percent area of ECM in TA muscles was unchanged
in Mmp13-/- compared to WT muscles (Fig. 1H/I), indicating no major changes in collagen
balance. Further, collagen packing density was also similar between strains (Fig. 1J).
Quantification of hydroxyproline performed on quadriceps muscles were consistent with
the morphological assessments in TA muscles, showing no apparent differences between
strains (Fig 1K). Thus, in unchallenged adult mice, the absence of MMP-13 did not manifest
in deficiencies in muscle function, fiber size, angiogenesis, or ECM content. However,
homeostatic muscle has virtually undetectable levels of MMP-13 [7], and compared to the
expression of other MMPs in muscle (Supplementary Fig. 2), suggesting that it might not
play a critical role in healthy adult muscle.

MMP-13 is required for efficient muscle regeneration
Muscles that undergo injury activate satellite cells, which differentiate and then
migrate and fuse to damaged fibers or to each other to form new muscle fibers, and this is
accompanied by a transient increase in MMP-13 activity [5]. To determine if loss of MMP-13
altered muscle regeneration, young adult WT and Mmp13-/- mice received CTX injections into
the TA muscles, which were then dissected after 7, 11, 14, and 21 days, and immunostained
for laminin and CD31 (Fig. 2A). At 7 days post CTX injection, fiber sizes from both Mmp13-/and WT muscles were significantly smaller than WT uninjured muscle fiber size, but they
were not significantly different from each other (Fig. 2B/C). By 11 days post CTX injection
the WT muscle fiber sizes were similar to uninjured sizes, but the Mmp13-/- fibers were
significantly smaller. The differences in fiber size persisted to 14 days post CTX injection,
but strains exhibited similar sizes by day 21. Hence, there was a delayed recovery of fiber
size during muscle regeneration following CTX injury in Mmp13-/- TA muscles. The smaller
fiber size at 14 days post CTX was accompanied by a reduced capillary density in Mmp13-/TA muscles (Fig. 2D). However, the number of regenerating fibers as marked by centrally
nucleated fibers was not significantly different from Mmp13-/- muscles at any time point (Fig.
2E). Fibers may undergo necrosis when regeneration is not optimal, with necrotic fibers
being marked by positive IgG staining (Fig. 2F) [45, 46]. Necrotic fibers were observed in
clusters in a subset of Mmp13-/- TA muscles at each of 7, 11, and 14 days post CTX injection,
while WT muscles lacked appreciable necrotic fibers at any time point, a difference that was
significant for a main effect in Mmp13-/- muscles (Fig. 2G). It may again be presumed that
a lack of MMP-13 would lead to an imbalance between ECM production and degradation,
favoring ECM accumulation. However, there was no significant difference in ECM area
between the strains at any time point after CTX injection (Fig. 2H/I). Because several MMPs
share common substrates, compensatory expression of other MMP family members could
occur in the absence of MMP-13. MMP-2 is the likely candidate as it has a similar timecourse
to MMP-13 during muscle regeneration [7]. mRNA levels of Mmp2 were transiently elevated
in TA muscles following CTX injection, but with no alteration in the timecourse in Mmp13-/TA muscles (Fig. 2J). Taken together, the absence of MMP-13 resulted in delayed resolution
of acute muscle damage.
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Fig. 2. Mmp13-/- muscles have impaired regeneration following cardiotoxin injury. (A) Examples of WT and Mmp13-/- TA
muscles with staining of laminin, CD31, and DNA on TA muscles 14 days after cardiotoxin (CTX) injection. Scale bar 50
μm. (B) The median fiber area is decreased for both genotypes 7 days after CTX and recovers to baseline by day 11 for
WT, but recovery is significantly delayed in Mmp13-/- TA muscles. (C) The cumulative distributions of fiber areas from WT
and Mmp13-/- TA muscles 7 days (WT N=8;Mmp13-/- N=4), 11 days (WT N=8;Mmp13-/- N=7), 14 days (WT N=6;Mmp13-/N=6), and 21 days (WT N=10;Mmp13-/- N=12) following CTX injections. The uninjured WT cumulative distribution
(black dotted line) is shown for reference with day 7. (D) The capillary density is significantly reduced at 14 days after
CTX in the Mmp13-/- TA muscles. (E) There was no significant difference in the percentage of centrally nucleated fibers
(CNF)s between WT and Mmp13-/- TA muscles throughout the injury recovery period. (F) Examples of WT and Mmp13/TA muscle 14 and 7 days post CTX, respectively, with staining of laminin, IgG to label damaged or necrotic fibers, and
DNA. WT Day 14 was used so that rare IgG positive fibers could be shown. Scale bar 50 μm. (G) There is a significant
main effect of Mmp13-/- compared to WT across the recovery timeframe. (H, I) The area fraction of ECM was similar for
WT and Mmp13-/- TA muscles following CTX injury. (J) There was a significant main effect of increased expression of
Mmp2 dependent on time post CTX injury, but no differences with respect to strain (all conditions N=4 per group). The *
represents a significant (p<0.05) difference between WT and Mmp13-/-, with the bar representing the range of fiber areas
that have a significant difference in the cumulative distribution. The † represents significant (p<0.05) difference between
injured and uninjured muscles.
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The most commonly used mouse model of muscular dystrophy, the mdx mouse, lacks
dystrophin expression and consequently undergoes chronic muscle degeneration and
regeneration cycles, and has elevated levels of MMP-13 [7]. Due to the impaired regeneration
observed following acute CTX injury, mdx mice were crossed with Mmp13-/- mice to determine
if the loss of MMP-13 exacerbated the dystrophic phenotype. Surprisingly, no significant
defects were observed in muscle function for adult male Mmp13-/-:mdx mice compared to mdx
mice in terms of maximum specific force, passive stiffness, or eccentric contraction induced
force loss in the EDL or diaphragm, which is known as the most severely affected muscle
[47], although there were apparent deficits in these measures compared to WT muscles
(Supplementary Fig. 1A-C). The lack of functional changes between mdx and Mmp13-/-:mdx
mice persisted out to 1 year of age, which was the longest time studied (data not shown).
Consistent with the lack of functional defect, the fiber size distribution was not significantly
shifted in Mmp13-/-:mdx mice relative to mdx mice in EDL muscles (Supplementary Fig. 1D/E).
Correspondingly, the percentage of centrally nucleated fibers and the capillary density were
unchanged between Mmp13-/-:mdx and mdx EDL and diaphragm muscles (Supplementary
Fig. 1F/G). Muscles undergoing chronic degeneration and regeneration are known to have
a subset of necrotic fibers, shown by positive IgG staining (Supplementary Fig. 1H). While
a small population was observed in mdx muscles, there was a significant main effect across
muscle for an increase in the population of necrotic fibers in Mmp13-/-:mdx, indicating a small
defect in the muscle fiber survival. The chronic damage in the mdx mice leads to elevated
ECM deposition and eventually fibrosis, yet the loss of MMP-13 in mdx mice did not result
in an increase in ECM area of the muscle. Thus, the small increase in necrotic fibers that
results from loss of MMP-13 is not sufficient to drive functional or morphological defects of
the muscle on the mdx background, where chronic injury and ECM remodeling occur in the
presence of high levels of several MMPs [7, 48].

Absence of MMP-13 alters the hypertrophic response to IGF-1
In additional to rapid growth during postnatal development, mature muscles are also
capable of undergoing profound hypertrophy in response to mechanical overload [49],
reduction of muscle growth inhibitors [49], or overexpression of hypertrophic signaling
molecules, such as Insulin-Like Growth Factor-1 (IGF-1) [50]. With Mmp13 being one of the
most upregulated genes in response to local IGF-1 overexpression [51], we anticipated that
MMP-13 contributed to IGF-1 induced hypertrophy. To determine if MMP-13 was necessary
for IGF-1 mediated hypertrophy, viral mediated gene transfer of IGF-1 was performed in
the anterior hindlimbs of young adult Mmp13-/- and WT mice, causing a 7-10 fold increase
in IGF-I levels (Fig. 3A). To ensure that IGF-1 led to an increase in MMP-13, enzyme activity
assays were performed on muscle lysates, and confirmed a significant increase in MMP13 activity in WT muscles injected with AAV-Igf1, whereas, muscles from Mmp13-/- mice
displayed no apparent MMP-13 activity in response to increased IGF-1 levels (Fig. 3B).
Consistent with previous studies, viral production of IGF-1 resulted in a 10-15% increase
in muscle mass relative to the contralateral limb muscles 4 weeks after injection, but this
effect was blunted in the Mmp13-/- muscles (Fig. 3C). Hypertrophy was driven primarily by
increased fiber size, which was evident in the EDL muscles of both mouse strains (Fig. 3D).
Further, WT EDL muscles also displayed a significant increase in centrally nucleated fibers
following increased IGF-1 expression, as with previous studies [52] (Fig. 3E). In contrast,
EDL muscles from Mmp13-/- mice lacked IGF-1 dependent increases in central nuclei. Hence,
hypertrophy was possible in the absence of MMP-13, but it was less robust and occurred
through a satellite cell independent mechanism.
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Fig. 3. Mmp13-/- muscles exhibit hypertrophy in response to IGF-1 but without satellite cell involvement. (A) IGF-I
content significantly increases in TA muscles of both WT and Mmp13-/- mice following injection with AAV-Igf1
(N=3 muscle pairs). (B) MMP-13 activity increased in response to IGF1 AAV in WT muscles, but not in muscles from
Mmp13-/- mice (N=3 muscles pairs). (C) Relative muscle mass increased following AAV-Igf1 injection in TA and
EDL muscles compared to contralateral control muscles regardless of genotype (N=6 muscle pairs), but muscles
from Mmp13-/- mice displayed a blunted hypertrophic response. (D) Median fiber areas significantly increased in
response to AAV-Igf1 injection in EDL muscles. (E) The percent of CNF increased in WT but not in EDL muscles
from Mmp13-/- mice in response to AAV-Igf1 injection. The * represents p<0.05 between +AAV and non-injected
muscles. The † represents p<0.05 between genotypes.

MMP-13 is critical for myoblast migration
Previous studies have demonstrated that MMP-13 is expressed by myoblasts in vitro
and modulates their migration [7]. To extend these findings, we examined muscle progenitor
cells migrating from single muscle fibers using live cell microscopy. Muscle progenitors were
tracked for migration and cell division following their exit from isolated fibers, 48 – 64 hours
following fiber isolation (Fig. 4A; Supplementary Videos for Fig. 4). Under standard primary
culture conditions containing 20% serum, no difference in migration velocity or proliferation
rate between WT and Mmp13-/- myoblasts was observed (Fig. 4B/C). Because serum contains
many MMPs that may mask effects of MMP-13 deficiency, serum levels were reduced to 2%.
In 2% serum, WT myoblast migration was minimally impacted, yet the Mmp13-/- myoblasts
migrated significantly more slowly when compared to WT myoblasts in 2% or Mmp13-/myoblasts in 20% serum conditions. Qualitatively, the Mmp13-/- myoblasts also showed less
directional persistence than the WT myoblasts. While the 2D migration of myoblasts was
impaired, other properties were unaffected by MMP-13 absence, including proliferation rate
(Fig. 4C), although reduced serum conditions generally lowered proliferation.
Migration in 2D does not necessarily require the cleavage of any MMP substrate, but
3D invasion assays require cells to penetrate ECM components in order to facilitate directed
migration. When basement membrane extract (BME) was used as a substrate in transwell
invasion assays for myoblasts isolated from muscle in bulk, there was robust invasion by WT
myoblasts, but the invasion was reduced by ~50% for the Mmp13-/- myoblasts (Fig. 4D/E).
Notably, neither WT nor Mmp13-/- myoblasts were able to penetrate a collagen I gel over a
24-hour period. Myoblasts from bulk isolation were also differentiated on top of either BME
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Figure 4

Fig. 4. Mmp13-/- myoblasts in vitro have
impaired migration. (A) A brightfield frame
of live cell microscopy with multicolored
fiber tracks showing the course of migration
over 14 hours in WT and Mmp13-/- primary
satellite cells. A fiber is shown on the left side
of the Mmp13-/- frame. Scale bar is 100 μm.
Representative videos are included in the
supplement. (B) Average velocity of migrating
cells in 2D from live cell experiments were
similar in WT cells (N=307) and Mmp13-/cells (N=215) at 20% serum and significantly
different between WT cells (N=27) and
Mmp13-/- cells (N=35) in 2% serum.
Numbers of cells analyzed are shown on
each column of the graph. (C) Proliferation
rate measured as cells are migrating in 2D
obtained from the same experiments as in B,
which consisted of cells from WT (N=9) fibers
and Mmp13-/- (N=7) fibers in 20% serum
and WT (N=6) fibers and Mmp13-/- (N=6)
fibers in 2% serum were not significantly
different between genotypes. (D) Examples
of 3D migration of WT and Mmp13-/- cells
showing bottom side of membrane with cells
invading the designated substrate (basement
membrane extract (BME) or collagen) over
the course of 24 hours. Scale bar = 50 μm.
(E) 3D migration of Mmp13-/- cells through
BME is impaired compared to WT cells, and
almost non-existent through collagen by cells
of both genotypes. 3 images per membrane
(N=3 membranes for each genotype and
substrate). (F) Examples of images of
myotube formation at day 2 of differentiation
from WT and Mmp13-/- myoblasts on BME
and collagen. Sarcomeric myosin heavy chain
(sMyHC) in red, phalloidin labeling actin in green, and DAPI labeling DNA. Scale bar = 50 μm. (G) The fusion index
(percentage of nuclei in myotubes of all nuclei) is not changed between genotypes at any timepoint or substrate.
There is a main effect of collagen substrates with less differentiation than BME substrates (N=3 wells per genotype
per substrate per day). The * represents p<0.05 difference between WT and Mmp13-/-;† represents a significant
difference within each genotype of serum conditions or substrate.

or collagen substrates to examine the role of MMP-13 in differentiation and myoblast fusion
using immunostaining for myosin by MF20 (in red) and actin labeling by phalloidin (in
green) (Fig. 4F). There was no significant difference in the fusion index between myoblasts
from WT and Mmp13-/- mice for either substrate (Fig. 4G). However, in both genotypes BME
served as a better substrate than collagen for myosin positive myotube formation, with a
significant main effect of the substrate. These data demonstrate that Mmp13-/- myoblasts are
impaired in 2D and 3D migration, but loss of MMP-13 does not have a dramatic impact on
their ability to proliferate, differentiate or fuse.
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Targeted loss of MMP-13 from myoblasts replicates impairments of total MMP-13 ablation
While the global Mmp13-/- mouse has defects in muscle regeneration, it is not known if
cells other than myoblasts produce MMP-13 needed for this process. A satellite cell specific
knockout of MMP-13, +scMmp13fl/fl, was used to elucidate the role of muscle progenitors in
expressing MMP-13 (Fig. 5A). Pilot studies in +scMmp13+/+ cells showed that 83±15% of the
cells were GFP positive indicating efficient TAM induction of the ROSA reporter (2 biological
replicates). A second strategy of model validation used bulk primary cultures from muscles
of +scMmp13fl/fl mice treated with TAM or vehicle, allowed to differentiate, and then subjected
to immunostaining for MMP-13. GFP positive myotubes had no evidence of MMP-13 staining,
even though contaminating fibroblasts had strong signal for MMP-13 (Supplementary Fig.
3). Thus, the intended deletion of Mmp13 from satellite cells was efficient and specific for
myogenic cells.
To confirm that the in vitro phenotype of +scMmp13fl/fl cells could replicate the global
knockout model, the migration velocity was measured as previously shown (Fig. 5B;
Supplementary Videos for Fig. 5). Consistent with Mmp13-/- myoblasts, tamoxifen (TAM)
treated +scMmp13fl/fl cells had a similar velocity to WT cells at 20% serum and cells of the
same genotype that were not exposed to TAM (-scMmp13fl/fl). However, while -scMmp13fl/fl
maintained a consistent velocity in 2% serum, +scMmp13fl/fl cells displayed a significant
decrease in migration velocity (Fig. 5C), similar to Mmp13-/- myoblasts in the same condition.
Taken together, the impairment of myoblast migration was dependent predominantly on
autocrine sources of MMP-13, rather than that secreted from fibers.
Muscles in +scMmp13fl/fl mice were examined early in life when satellite cell incorporation
into growing muscle fibers is most dramatic [53], through removal of MMP-13 from the Pax7
lineage +scMmp13fl/fl starting postnatal Day 1 (Fig. 5D). The presence of GFP positive fibers
in +scMmp13fl/fl EDL muscles indicated that Mmp13-/- satellite cells fused to growing fibers
(Fig. 5E). However, EDL muscle mass was significantly smaller compared to muscles from
littermate and sex-matched -scMmp13fl/fl mice (Fig. 5F). This effect was not attributable to the
early TAM injection as Mmp13+/+ mice with and without TAM injection showed no changes
in muscle mass. Importantly, the growth impairment occurred only when TAM treatment
began early in postnatal life, as the same treatment regimen employed at Day 14 of life did
not exhibit growth impairments (Fig. 5F). Hence, MMP-13 expressed by satellite cells is
important for normal post-natal growth.
Our initial observation of regeneration defects used mice with complete ablation of
Mmp13. To clarify if MMP-13 production by satellite cells contributed to regeneration, we
performed CTX injection into muscles from +scMmp13fl/f mice, mice with the same genotype
but without TAM injection (-scMmp13fl/fl), and mice treated with TAM but lacking floxed
alleles of Mmp13 (+scMmp13+/+) (Fig. 5G). GFP positive fibers were evident in regenerating
muscles from the TAM injected animals (Fig. 5H), and centrally nucleated fibers were
apparent in all CTX treated muscles, indicating robust satellite cell fusion. Analysis of GFP
positive fibers in +scMmp13fl/fl and +scMmp13+/+ mice revealed significantly smaller muscles
fibers in +scMmp13fl/fl mice at 11 and 14 days after CTX injection (Fig. 5I/J). This difference
recapitulated much of the defect observed in Mmp13-/- muscles injected with CTX. Together
these results show that the impaired regenerative capacity associated with Mmp13-/muscles is present when MMP-13 is removed only from muscle progenitors, implicating
muscle progenitors as a critical source of MMP-13 in regenerating muscle, despite the likely
production of MMP-13 by a multitude of cell types present during the repair process.
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Fig. 5. Satellite cell expression of MMP-13 underlies the Mmp13-/- phenotype. (A) Adult mice with Mmp13fl/fl Pax7CreER
mT/mG received intraperitoneal injections of tamoxifen (TAM) (+sc) or corn oil (-sc) for 5 consecutive days 1 week prior
to tissue harvest for single fiber culture. (B) A frame of live cell microscopy with multicolored fiber tracks showing the
course of migration over 14 hours of cells from -sc/+scMmp13fl/fl mice (Sup Videos Overlay_RG-Control.avi and Overlay_
RG-ko.avi). The +sc cells express GFP in satellite cells due to recombination of the mT/mG reporter element that expresses
TdTomato in -sc cells. Scale bar = 100 μm. Representative videos are included in the supplement. (C) There is a significant
reduction in migration velocity of +sc cells (N=114) that lack MMP-13 compared to -sc cells (N=103) expressing MMP-13
at 2% serum. In 20% serum +sc cells (N=73) do not exhibit impaired migration. (D) Similar schematic to (A), with TAM
injections beginning on Day 1 or 14 of life, and mice being dissected at day 28 of life. (E) Examples of +sc/-scMmp13fl/fl
TA muscles stained with laminin and expressing GFP indicating derivation from Pax7 cells recombined to ablate Mmp13.
Scale bar 50 μm. (F) Muscle mass is significantly reduced in EDLs from +sc (N=5) compared to -scMmp13fl/fl (N=7) EDL
muscles when TAM treatment occurred at Days 0-4. EDL mass was not reduced when TAM treatment occurred starting
at Day 14 (N=3). In scMmp13+/+ mice, TAM treatment starting at Day 0 did not alter EDL mass (N=3 –sc, and N=4 +sc).
(G) Similar schematic as (A) except at day 0 adult mice are injected with CTX and dissected at day 11 and day 14 of
regeneration. Additionally, a mouse with Mmp13+/+ Pax7CreER mT/mG (+scMmp13+/+) was used as a further control for
TAM injection. (H) Examples of +sc/-scMmp13fl/fl and +scMmp13+/+ TA muscles stained with laminin and expressing GFP
indicating derivation from Pax7 cells recombined to express GFP from 14 days post CTX injection. Scale bar 50 μm. The
cumulative distributions from (I) 11 days (Mmp13+/+ N=6;Mmp13fl/fl N=6) and (J) 14 days (Mmp13+/+ N=7;Mmp13fl/fl
N=3) following CTX injections show significantly smaller fibers in +scMmp13fl/fl compared to +scMmp13+/+ muscles,
similar to global Mmp13-/-. The * represents a significant (p<0.05) difference between satellite cells which express and do
not express MMP-13, with the bar representing the range of fiber areas that have a significant difference in the cumulative
distribution. The † represents a significant difference between each genotype with TAM treatment.
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Discussion

The goal of this study was to determine the role of MMP-13 in muscle homeostasis,
regeneration, and growth. Several studies have taken advantage of the Mmp13-/- mouse line,
and other than abnormal growth plates [13, 54], no other phenotypes have been described
[55-57]. While healthy adult skeletal muscle has minimal MMP-13 activity, our findings
place MMP-13 among the family of MMPs with important roles in skeletal muscle repair and
growth. Even though MMP-13 may be provided by other cells and by fibers within the muscle
bed, defects in growth and regeneration persist in the absence of satellite cell expression of
MMP-13. Thus, a critical partner and source of MMP-13 activity is the satellite cell, which
relies on MMP-13 for migration.
As skeletal growth and muscle growth are linked, the impact of MMP-13 on bone growth
may have indirectly affected muscle size in young mice. However, the levels of MMP-13 are
negligible in healthy adult muscle, which may underly the minimal impact of this collagenase
in homeostatic muscle. Similar results have been reported for MMP-2 deficient mice, which
have unchanged fiber size and capillary density at baseline conditions [23]. A more relevant
situation to examine MMP-13 actions in muscle is during regeneration, given MMP-13’s
known role in wound healing [54], and previous demonstrations of MMP-13 up-regulation
7-14 days after CTX injection (GDS234) [7, 58]. Our current findings reflect this timecourse,
with delayed regeneration in the intermediate timepoints, but the possible functional overlap
within the MMP family may have enabled resolution of damage by day 21. Despite the clear
phenotype during regeneration in mice lacking MMP-13, the collagenase’s absence had no
consistent impact on collagen area of the muscle. In part, this points to the extensive overlap
in target substrates by the MMP family [59], as well as the several-fold lower MMP-13 levels
with respect to its other family members. However, the lack of an MMP-13 dependent impact
on collagen content is distinct from other clinical situations, such as idiopathic pulmonary
fibrosis. Absence of MMP-13 in a bleomycin murine idiopathic pulmonary fibrosis model
results in excessive ECM deposition, supporting the need for MMP-13 for collagenolytic
activity and to counter inflammatory-mediated ECM production [60]. Thus, in muscle,
despite the requirement for MMP-13 in the efficient resolution of damage, it does not appear
to be essential as a counterbalance to progressive fibrosis associated with inflammation.
This situation is exemplified in the clinically relevant model of DMD, the mdx mouse,
which undergoes persistent injury and regeneration and progressive fibrosis, which is, in
part, due to heightened chronic inflammation. By crossing mdx and Mmp13-/- mouse lines,
we could then determine the role of MMP-13 in chronically damaged muscle. We evaluated
multiple functional muscle parameters known to be disrupted in the mdx mouse; specific
force, passive stiffness [38], and susceptibility to ECC injury displayed no significant changes
caused by lack of MMP-13, although all of these parameters were different than WT muscles.
Likewise, muscles were histologically similar, which is in contrast to the effects observed
when other MMPs are altered in mdx muscle. MMP-2 ablation in mdx mice has shown a
decrease in both centrally and peripherally nucleated fiber sizes in TA muscle with a similar
effect in capillary density linked to reduced VEGF availability [23]. Ablating MMP-9 from the
mdx mouse has protective effects, with increased specific force associated with a decrease
in inflammatory factors [24]. However, a confounding observation is that increased MMP-9
expression protected mdx muscle with fiber hypertrophy and minimized fibrosis [25]. These
previous studies highlight the multifunctional roles of MMPs in muscle disease, which can
promote inflammation, inhibit fibrosis, support angiogenesis, and increase damage. The
effect of an MMP likely depends on timing and location of MMP activity. These factors could
neutralize each other in the Mmp13-/-:mdx muscle to maintain the same muscle function. The
lack of histological phenotype suggests that MMP-13 is compensated for by other proteases
or is not required in mdx muscle. As observed in the high serum 2D migration experiments,
high levels of MMPs can mask a role for MMP-13; similarly, the high overall MMP levels
persistent in mdx muscle [20] could hide a more severe phenotype from Mmp13-/-:mdx
mice. As myoblasts appear unable to migrate through a dense collagen network, myoblast
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migration through the fibrotic mdx muscles may be severely impaired regardless of the
ability to express MMP-13. MMP-13 can cleave fibrillar collagen type II much faster than
collagen I or III [59], and as the ECM of muscle is predominantly comprised collagens types I
and III, with little type II [61] MMP-13 may serve little role in satellite cell migration through
the interstitial matrix. Alternatively, the progressive crosslinking within the dystrophic ECM
may prevent the ability for MMP-13 to cleave interstitial fibrillar collagens [40]. This would
be in contrast to the denatured collagen substrates for MMP-2/9, which may still persist in
the dystrophic muscle.
Despite the lack of phenotype observed in Mmp13-/-:mdx mice, MMP-13 as a collagenase
may well limit collagen accumulation if expressed in fibrotic muscle at supraphysiological
levels. The determination of what levels would be therapeutic could be minimal given the
relatively low abundance of this MMP. Activation of MMPs with relaxin has been shown to
enhance muscle regeneration and limit fibrosis [62]. It is intriguing that, as opposed to limb
muscle, the diaphragm of mdx mice (GDS641) [63] and muscles from DMD patients (GDS3027)
[64] do not have elevated Mmp13 expression. This is despite dramatic upregulation of
fibrillar collagen and TIMPs, suggesting that MMP-13 overexpression may help muscles
restore collagen balance. Alternatively, supplementing MMP-13 may enhance migration
even in the fibrotic environment, as a similar collagenase, MMP-1, which enhances myoblast
engraftment in skeletal muscle [65]. The potential of MMP-13 to serve as a supplementary
therapy in muscle disease may exist, but this was not evaluated in this study.
Hypertrophy of muscle fibers necessitates the remodeling of the ECM that surrounds
them to afford their expansion, and thus notionally, MMP activity would be required. In line
with this premise, Mmp13 expression is elevated from day 7 to day 14 synergist ablation
model of hypertrophy (GDS4932) [66]. MMP-2 ablation has been shown to limit muscle
hypertrophy in a synergistic ablation model as well [67], supporting the role for MMPs in
muscle growth. Because our initial indication that MMP-13 was expressed in muscle arose
following increased IGF-1 levels, we reasoned that elevated MMP-13 contributed to IGF-1
dependent actions in skeletal muscle [51], and it also provided a way to validate the ablation
of MMP-13 in the knock out mice. In the absence of MMP-13, IGF-1 mediated hypertrophy still
occurred; however, the surprising reduction of centrally nucleated muscle fibers suggested
an inhibition on satellite cell actions led to the blunted hypertrophic response. Previous
work removing satellite cell activity through irradiation demonstrated an approximate 50%
decrease in muscle hypertrophy in response to IGF-1 [50], and more recently, satellite cell
ablation prevented hypertrophy in muscle overload experiments [68]. However, a limitation
of this former study was the elimination of many cells within the muscle in addition to
satellite cells. Indeed, the current observation is more reflective of the ability of muscle to
grow following genetic ablation of satellite cells dependent on age [49]. While we did not
pursue longer term evaluation of hypertrophy in this model, it is clear that MMP-13 is not
required for hypertrophy per se, but it is important for the incorporation of satellite cells to
growing fibers.
The above experiments suggested that satellite cells suffered the primary consequences
of MMP-13 loss. As such, satellite cell migration in vitro was also impaired, even when
only satellite cell expression of Mmp13 was targeted. From a broader perspective, MMP13 mediated migration is a phenomenon shared with other cell types in physiological and
pathological conditions, including keratinocytes [54] and melanocytes [69], where myoblasts
appear to have adopted a similar use to ensure efficient muscle growth and repair. Previous
work had shown that in the C2C12 myogenic cell line a small molecular inhibitor of MMP13 decreased migration and transcriptional markers of myogenic differentiation [7], with
no change in proliferation or fusion. Our current work is consistent with this study in that
the principal effect of MMP-13 on myogenic cells is on migration. As expected, Mmp13-/primary myoblasts were not able to migrate through a fibrillar collagen I substrate in 3D,
given collagen is MMP-13’s primary substrate. However, fibrillar collagen also presented a
virtually impenetrable barrier to WT cells, which was recently observed of mouse myoblasts
in a related study [70]. This indicates that endogenous levels of MMP-13 are not sufficient
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to migrate through a collagen network similar to the interstitial matrix, or dense networks
in fibrotic muscle. The impact of MMP-13 was readily observed in cells migrating through
BME, which is a condition that mimics the basement membrane juxtaposed to muscle fibers
[71]. While BME does not contain fibrillar collagen, it does contain many MMP-13 substrates,
including fibronectin [59]. MMP-13’s role in 2D is less readily apparent, and required low
serum levels to unmask the impact that loss of MMP-13 had on migration. Estimations of
MMP-13 levels in serum are extremely low in comparison to other MMPs, where in human
serum it is 4 orders of magnitude lower than MMP-2 and -9 [72], supporting our speculation
that other MMPs can substitute for the absence of MMP-13 at high concentrations. For
myoblasts, the local MMP-13 source provides sufficient activity in their microenvironment
to move. In addition, myoblasts could secrete their own matrix components they can utilize
as scaffolds on which to migrate, or a role for MMP-13 in the migration machinery in the cell.
MMP-13 has been observed in myoblasts intracellularly, especially during proliferation and
later phases of myoblast maturation [7].
Many cells in addition to myoblasts within the muscle milieu may secrete MMP-13,
including fibroblasts [73] and macrophages [44] that are present in muscle tissue. In order
to selectively remove MMP-13 from myogenic cells in a manner that did not interfere with
development, a tamoxifen inducible system was used [31]. Despite the expression of MMP13 by other cell types, removing MMP-13 from satellite cells largely mirrored the results of
the global Mmp13-/- mice in muscle regeneration. This result establishes myogenic cells as a
critical source of MMP-13 in skeletal muscle regeneration. MMPs are also known to be active
during development, as is the case in skeletal muscle [74]. While adult mice had no overt
phenotype, investigation of 4-week-old mice revealed a delayed increase in muscle mass
when MMP-13 is removed specifically from satellite cells, and a general deficit in growth
at the same age with total MMP-13 ablation. This coincides with a period in which Pax7+
satellite cells are highly active in providing new myonuclei [32], which may continue into
pre-puberty [75]. While we can establish that MMP-13 is important in satellite cells in vivo,
we cannot definitively conclude if myoblast migration is altered in vivo in Mmp13-/- cells.
However, recent intravital imaging of myoblasts in regenerating muscle does confirm that
mammalian myoblasts are highly migratory cells [76], further supporting evidence for MMP13’s role in muscle regeneration to be a consequence of satellite cell migration.
The satellite cell specific knockout of MMP-13 eliminates inflammatory cells and
interstitial cells as being critical sources of MMP-13 during regeneration, however it
remains to be determined if the satellite cells themselves are a critical source, or if newly
regenerated fibers derived from the satellite cells lacking Mmp13 are the limitation. In our
previous studies, we noted that Mmp13 expression occurred late in the differentiation
process as nascent myotubes matured, as well as later in regenerating muscle [7]. Hence, this
suggested that muscle fibers were the primary source of MMP-13. ECM remodeling around
the forming muscle fiber could then enable the fiber to expand in girth or digest the ECM to
afford satellite cell incorporation. In addition to the muscle fibers, we also observed that
satellite cells exhibited positive MMP-13 staining particularly as they proliferated, where
the intensity of MMP-13 signal was greatest on the side opposing the cleavage furrow. This
suggested that a second source of MMP-13 might complement that from the muscle fibers and
enable satellite cells to digest the ECM as they moved through it. Indeed, the live cell imaging
analysis of satellite cells lacking MMP-13 move more slowly, regardless of whether the cells
are from mice with total MMP-13 ablation or satellite specific deletion. Our interpretation
of these findings must now acknowledge that the source of MMP-13 is critical. Even though
the satellite cell production of MMP-13 may be small with respect to that from the muscle
fibers or other cell types, the satellite cell source appears to be necessary to enable satellite
cell migration, and their contribution to regeneration and muscle growth.
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